0.20
price down icon8.72%   -0.0191
after-market Dopo l'orario di chiusura: .21 0.010 +5.00%
loading
Precedente Chiudi:
$0.2191
Aprire:
$0.219
Volume 24 ore:
18.65M
Relative Volume:
0.36
Capitalizzazione di mercato:
$19.86M
Reddito:
-
Utile/perdita netta:
$-21.91M
Rapporto P/E:
-0.1342
EPS:
-1.49
Flusso di cassa netto:
-
1 W Prestazione:
-3.89%
1M Prestazione:
-8.13%
6M Prestazione:
-88.10%
1 anno Prestazione:
-94.29%
Intervallo 1D:
Value
$0.1978
$0.219
Intervallo di 1 settimana:
Value
$0.1978
$0.2394
Portata 52W:
Value
$0.08
$3.51

Incannex Healthcare Inc Stock (IXHL) Company Profile

Name
Nome
Incannex Healthcare Inc
Name
Telefono
61 409 840 786
Name
Indirizzo
8 CENTURY CIRCUIT, NORWEST NSW
Name
Dipendente
9
Name
Cinguettio
Name
Prossima data di guadagno
Name
Ultimi documenti SEC
Name
IXHL's Discussions on Twitter

Confronta IXHL con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Drug Manufacturers - Specialty & Generic icon
IXHL
Incannex Healthcare Inc
0.20 19.86M 0 -21.91M 0 -1.49
Drug Manufacturers - Specialty & Generic icon
RGC
Regencell Bioscience Holdings Ltd
23.70 303.95B 0 -5.87M -767.30K -0.45
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
157.34 74.39B 9.29B 2.52B 2.28B 5.57
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
10.49 48.97B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
14.72 47.39B 30.08B 710.16M 4.45B 0.2182
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
16.97 20.17B 16.54B -1.64B 749.00M -1.45

Incannex Healthcare Inc Borsa (IXHL) Ultime notizie

pulisher
Jun 18, 2025

Incannex Flat on Looking Ahead to Clinical Trial - Baystreet.ca

Jun 18, 2025
pulisher
Jun 18, 2025

Incannex Achieves Milestone in Sleep Apnea Drug Trial - TipRanks

Jun 18, 2025
pulisher
Jun 18, 2025

Incannex completes database lock for sleep apnea drug trial - Investing.com

Jun 18, 2025
pulisher
Jun 18, 2025

Incannex achieves key milestone with database lock for RePOSA Phase 2 trial of IHL-42X - TradingView

Jun 18, 2025
pulisher
Jun 18, 2025

Incannex forms joint venture with Mind Medicine Australia for clinic By Investing.com - Investing.com India

Jun 18, 2025
pulisher
Jun 17, 2025

Incannex forms joint venture with Mind Medicine Australia for clinic - Investing.com

Jun 17, 2025
pulisher
Jun 17, 2025

Incannex Healthcare Announces Psychedelic Therapies Joint Venture - TipRanks

Jun 17, 2025
pulisher
Jun 17, 2025

Incannex Healthcare Forms Joint Venture With Mind Medicine Australia To Expand Access To Psychedelic-Assisted Therapy - MarketScreener

Jun 17, 2025
pulisher
Jun 17, 2025

Incannex Healthcare Forms Joint Venture with Mind Medicine Australia to Expand Access to Psychedelic-Assisted Therapy - The Manila Times

Jun 17, 2025
pulisher
Jun 17, 2025

Incannex Healthcare Inc. Forms Joint Venture with Mind Medicine Australia for Psychedelic-Assisted Therapy Clinic in Melbourne - Nasdaq

Jun 17, 2025
pulisher
Jun 17, 2025

Groundbreaking Partnership: Incannex and Mind Medicine Launch Australia's Largest Psychedelic Therapy Center - Stock Titan

Jun 17, 2025
pulisher
Jun 13, 2025

Incannex Healthcare Seeks Nasdaq Transfer to Meet Listing Rules By Investing.com - Investing.com Canada

Jun 13, 2025
pulisher
Jun 13, 2025

Incannex Healthcare Seeks Nasdaq Transfer to Meet Listing Rules - Investing.com

Jun 13, 2025
pulisher
Jun 13, 2025

Incannex Healthcare Transfers Listing to Nasdaq Capital Market - TipRanks

Jun 13, 2025
pulisher
Jun 12, 2025

Incannex Healthcare Cancels Series A Warrants - TipRanks

Jun 12, 2025
pulisher
Jun 12, 2025

Incannex Healthcare Cancels All Outstanding Series A Warrants Following Strategic ATM Execution - The Manila Times

Jun 12, 2025
pulisher
Jun 12, 2025

Incannex Cancels All Warrants, Removes 347M Share Dilution Before Critical Sleep Apnea Trial Data - Stock Titan

Jun 12, 2025
pulisher
Jun 06, 2025

Incannex Healthcare Inc. Provides Clinical Program Update on IHL-42X, an Oral Once-Daily Treatment for Obstructive Sleep Apnea (OSA) - Revista ADVFN

Jun 06, 2025
pulisher
Jun 06, 2025

Incannex Healthcare Inc. Reports Fiscal Third Quarter 2025 Financial Results and Business Updates - mx.advfn.com

Jun 06, 2025
pulisher
Jun 06, 2025

Incannex Healthcare Inc. Advances IHL-42X RePOSA Trial to Phase 3 Following FDA Protocol Clearance - mx.advfn.com

Jun 06, 2025
pulisher
Jun 04, 2025

Incannex Healthcare Inc. Announces Pricing of $12.5 Million Private Placement Priced at the Market Under Nasdaq Rules - mx.advfn.com

Jun 04, 2025
pulisher
Jun 03, 2025

Incannex Expands Advisory Board for OSA Program - TipRanks

Jun 03, 2025
pulisher
Jun 03, 2025

Incannex Healthcare Inc. Appoints Four Experts to IHL-42X Obstructive Sleep Apnea Clinical Advisory Board - Nasdaq

Jun 03, 2025
pulisher
Jun 03, 2025

Harvard and Emory Leaders Join Incannex's Sleep Apnea Program Ahead of Critical Phase 2 Data - Stock Titan

Jun 03, 2025
pulisher
May 31, 2025

Cannabis Stocks To Add to Your Watchlist – May 29th - Defense World

May 31, 2025
pulisher
May 30, 2025

Incannex advances to phase 3 trial for sleep apnea treatment By Investing.com - Investing.com South Africa

May 30, 2025
pulisher
May 30, 2025

Cannabis Stocks To ResearchMay 25th - MarketBeat

May 30, 2025
pulisher
May 30, 2025

Cannabis Stocks To Consider – May 28th - Defense World

May 30, 2025
pulisher
May 29, 2025

Incannex Healthcare Advances RePOSA Trial to Phase 3 - TipRanks

May 29, 2025
pulisher
May 29, 2025

Incannex advances to phase 3 trial for sleep apnea treatment - Investing.com Australia

May 29, 2025
pulisher
May 29, 2025

Incannex Healthcare Advances IHL-42X Reposa Trial To Phase 3 Following FDA Protocol Clearance - marketscreener.com

May 29, 2025
pulisher
May 29, 2025

Breakthrough: FDA Green-Lights Phase 3 Trial for Revolutionary Oral Sleep Apnea Treatment - Stock Titan

May 29, 2025
pulisher
May 29, 2025

Incannex cancels remaining Series A Warrants to reduce dilution By Investing.com - Investing.com South Africa

May 29, 2025
pulisher
May 29, 2025

Promising Cannabis Stocks Worth Watching – May 27th - Defense World

May 29, 2025
pulisher
May 28, 2025

Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 3Q 2025 - BioSpace

May 28, 2025
pulisher
May 28, 2025

Incannex Cancels Series A Warrants to Strengthen Capital - TipRanks

May 28, 2025
pulisher
May 28, 2025

Incannex cancels remaining Series A Warrants to reduce dilution - Investing.com

May 28, 2025
pulisher
May 28, 2025

Incannex Healthcare Inc. Enters Agreement to Cancel Remaining Series A Warrants, Eliminating Up to 347.2 Million Shares from Potential Dilution Ahead of IHL-42X Phase 2 Topline Results - The Manila Times

May 28, 2025
pulisher
May 28, 2025

Incannex Cancels 347M Share Warrant Dilution Before Crucial Sleep Apnea Drug Data Release - Stock Titan

May 28, 2025
pulisher
May 28, 2025

Incannex Healthcare Amends ATM Sales Agreement - TipRanks

May 28, 2025
pulisher
May 28, 2025

SEC Form 424B5 filed by Incannex Healthcare Inc. - Quantisnow

May 28, 2025
pulisher
May 27, 2025

Why E2open Shares Are Trading Higher By 25%; Here Are 20 Stocks Moving Premarket - Benzinga

May 27, 2025
pulisher
May 27, 2025

Cannabis Stocks To Research – May 25th - Defense World

May 27, 2025
pulisher
May 26, 2025

Cannabis Stocks To Follow NowMay 24th - MarketBeat

May 26, 2025
pulisher
May 26, 2025

Cannabis Stocks To Follow Now – May 24th - Defense World

May 26, 2025
pulisher
May 25, 2025

Best Cannabis Stocks To Follow Now – May 23rd - Defense World

May 25, 2025
pulisher
May 24, 2025

Top Cannabis Stocks To Keep An Eye On – May 22nd - Defense World

May 24, 2025
pulisher
May 23, 2025

Best Cannabis Stocks To Watch TodayMay 18th - MarketBeat

May 23, 2025
pulisher
May 22, 2025

Top Cannabis Stocks To Follow Now – May 20th - Defense World

May 22, 2025
pulisher
May 21, 2025

Cannabis Stocks To Follow Today – May 19th - Defense World

May 21, 2025
pulisher
May 21, 2025

Incannex's Big Leap Forward With Obstructive Sleep Apnea Study - Finimize

May 21, 2025

Incannex Healthcare Inc Azioni (IXHL) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$13.35
price down icon 0.82%
$8.85
price down icon 0.23%
$125.80
price down icon 0.59%
$286.39
price down icon 1.50%
drug_manufacturers_specialty_generic RDY
$15.31
price up icon 0.53%
$16.97
price up icon 0.12%
Capitalizzazione:     |  Volume (24 ore):